KRT19 and thymoma: Based on the same PRM validation sample batch as described before, we also examined TSCC/thymoma marker candidates such as CNOT2/9, SHMT1, VCAN, HTRA1, and TIMP1 in parallel with CK19 in the PRM analysis (for raw fragment abundances of all PRM samples, see Table S3).